| mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
3e-05 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |